keynote-a18: pembro or placebo with chemoradiotherapy in newly diagnosed high-risk cervical cancer
Published 1 month ago • 105 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:14
keynote-a18: pembrolizumab with chemoradiotherapy for advanced cervical cancer
-
7:18
keynote-826: pembrolizumab chemotherapy vs placebo chemotherapy for cervical cancer
-
3:15
highlights on pembro crt in high-risk locally advanced cervical cancer: the keynote-a18 study
-
1:16
keynote 826: pembrolizumab chemo in patients with advanced cervical cancer
-
2:26
keynote-826: pembrolizumab plus chemotherapy for patients with metastatic cervical cancer
-
6:38
pembrolizumab with chemotherapy as first line for metastatic cervical cancer
-
26:28
cervical cancer: key data review | 2022 evolution conference
-
0:15
#pocus case of the month: october 2018
-
3:18
gynecologic oncology at esmo congress 2021: trial study in cervical cancer
-
3:23
#esmo23 - prof. sven mahner: keynote a18 studie: pembrolizumab plus chemotherapie beim lokal for...
-
13:03
early tnbc - pembrolizumab chemotherapy: pathologic complete response in key subgroups
-
2:56
keynote-010: pembrolizumab, anti-pd-1, for advanced nsclc with pd-l1 expression
-
19:27
sabcs2014: analysis of the soft trial: prudence francis
-
45:24
state of the fes center (2018)
-
11:50
new advances in head & neck cancers - dr. kathryn gold, part 1
-
5:10
october 2022 case of the month
-
15:38
buncombe life - breast & cervical cancer control program (bcccp)
-
4:16
rescuer: resistance under combinatorial treatment in er and er- breast cancer